SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-234487
Filing Date
2024-10-08
Accepted
2024-10-08 17:26:01
Documents
35
Period of Report
2024-10-04
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d836681d8k.htm   iXBRL 8-K 355507
2 EX-3.1 d836681dex31.htm EX-3.1 7472
3 EX-3.2 d836681dex32.htm EX-3.2 48785
4 EX-3.3 d836681dex33.htm EX-3.3 139758
5 EX-10.14 d836681dex1014.htm EX-10.14 104082
6 EX-10.15 d836681dex1015.htm EX-10.15 114922
7 EX-10.16 d836681dex1016.htm EX-10.16 237156
8 EX-10.17 d836681dex1017.htm EX-10.17 188009
9 EX-10.18 d836681dex1018.htm EX-10.18 150678
10 EX-10.19 d836681dex1019.htm EX-10.19 40005
11 EX-10.20 d836681dex1020.htm EX-10.20 84617
12 EX-10.21 d836681dex1021.htm EX-10.21 35191
13 EX-10.22 d836681dex1022.htm EX-10.22 72292
14 EX-10.23 d836681dex1023.htm EX-10.23 148137
15 EX-21.1 d836681dex211.htm EX-21.1 1902
16 EX-23.1 d836681dex231.htm EX-23.1 2167
17 EX-99.1 d836681dex991.htm EX-99.1 244535
18 EX-99.2 d836681dex992.htm EX-99.2 212884
19 EX-99.3 d836681dex993.htm EX-99.3 227588
20 EX-99.4 d836681dex994.htm EX-99.4 14389
25 GRAPHIC g836681dsp109b.jpg GRAPHIC 12136
26 GRAPHIC g836681g20k95.jpg GRAPHIC 13993
  Complete submission text file 0001193125-24-234487.txt   3148509

Data Files

Seq Description Document Type Size
21 XBRL TAXONOMY EXTENSION SCHEMA okur-20241004.xsd EX-101.SCH 3224
22 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE okur-20241004_def.xml EX-101.DEF 14631
23 XBRL TAXONOMY EXTENSION LABEL LINKBASE okur-20241004_lab.xml EX-101.LAB 24182
24 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE okur-20241004_pre.xml EX-101.PRE 15567
37 EXTRACTED XBRL INSTANCE DOCUMENT d836681d8k_htm.xml XML 6085
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40315 | Film No.: 241361006
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)